Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences Total Liabilities 2010-2023 | USNA

USANA Health Sciences total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
USANA Health Sciences Annual Total Liabilities
(Millions of US $)
2023 $136
2022 $162
2021 $183
2020 $199
2019 $165
2018 $163
2017 $156
2016 $145
2015 $142
2014 $120
2013 $108
2012 $82
2011 $71
2010 $70
2009 $49
USANA Health Sciences Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $136
2023-09-30 $131
2023-06-30 $134
2023-03-31 $150
2022-12-31 $162
2022-09-30 $145
2022-06-30 $154
2022-03-31 $183
2021-12-31 $183
2021-09-30 $180
2021-06-30 $173
2021-03-31 $182
2020-12-31 $199
2020-09-30 $188
2020-06-30 $163
2020-03-31 $156
2019-12-31 $165
2019-09-30 $149
2019-06-30 $148
2019-03-31 $160
2018-12-31 $163
2018-09-30 $164
2018-06-30 $146
2018-03-31 $145
2017-12-31 $156
2017-09-30 $128
2017-06-30 $142
2017-03-31 $118
2016-12-31 $145
2016-09-30 $136
2016-06-30 $136
2016-03-31 $187
2015-12-31 $142
2015-09-30 $126
2015-06-30 $124
2015-03-31 $122
2014-12-31 $120
2014-09-30 $117
2014-06-30 $101
2014-03-31 $92
2013-12-31 $108
2013-09-30 $93
2013-06-30 $85
2013-03-31 $81
2012-12-31 $82
2012-09-30 $77
2012-06-30 $77
2012-03-31 $73
2011-12-31 $71
2011-09-30 $70
2011-06-30 $56
2011-03-31 $55
2010-12-31 $70
2010-09-30 $72
2010-06-30 $45
2010-03-31 $46
2009-12-31 $49
2009-09-30 $59
2009-06-30 $67
2009-03-31 $79
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.924B $0.921B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.263B 32.23
Chugai Pharmaceutical (CHGCY) Japan $51.982B 23.24
Takeda Pharmaceutical (TAK) Japan $42.124B 8.53
Merck (MKGAF) Germany $23.587B 22.87
Astellas Pharma (ALPMY) Japan $17.518B 27.66
Sandoz Group AG (SDZNY) Switzerland $15.512B 0.00
Neurocrine Biosciences (NBIX) United States $14.281B 39.09
Shionogi (SGIOY) Japan $13.629B 11.85
United Therapeutics (UTHR) United States $12.075B 12.87
Catalent (CTLT) United States $9.999B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.716B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.965B 7.66
Revolution Medicines (RVMD) United States $6.433B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.491B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.628B 0.00
Alpine Immune Sciences (ALPN) United States $4.456B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.094B 0.00
Summit Therapeutics (SMMT) United States $3.166B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.105B 0.00
Corcept Therapeutics (CORT) United States $2.867B 25.98
PTC Therapeutics (PTCT) United States $2.610B 0.00
Dyne Therapeutics (DYN) United States $2.512B 0.00
Indivior (INDV) United States $2.391B 11.33
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.946B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.937B 18.85
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.532B 0.00
Soleno Therapeutics (SLNO) United States $1.526B 0.00
Pacira BioSciences (PCRX) United States $1.467B 13.94
Xencor (XNCR) United States $1.385B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.335B 0.00
4D Molecular Therapeutics (FDMT) United States $1.326B 0.00
Cronos Group (CRON) Canada $1.154B 0.00
Enliven Therapeutics (ELVN) United States $1.120B 0.00
Collegium Pharmaceutical (COLL) United States $1.102B 6.59
Ironwood Pharmaceuticals (IRWD) United States $1.039B 16.19
Cassava Sciences (SAVA) United States $1.034B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.012B 0.00
Ocular Therapeutix (OCUL) United States $0.971B 0.00
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
ProKidney (PROK) United States $0.869B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.823B 0.00
Sage Therapeutics (SAGE) United States $0.723B 0.00
Lyell Immunopharma (LYEL) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.656B 0.00
Savara (SVRA) United States $0.652B 0.00
Altimmune (ALT) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.562B 7.18
Verve Therapeutics (VERV) United States $0.536B 0.00
OmniAb (OABI) United States $0.533B 0.00
Bioventus (BVS) United States $0.525B 20.09
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.491B 0.00
Esperion Therapeutics (ESPR) United States $0.491B 0.00
Heron Therapeutics (HRTX) United States $0.485B 0.00
Korro Bio (KRRO) United States $0.475B 0.00
Larimar Therapeutics (LRMR) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.378B 71.25
Nanobiotix S.A (NBTX) France $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Fractyl Health (GUTS) United States $0.320B 0.00
Xeris Biopharma Holdings (XERS) United States $0.299B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.58
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Pyxis Oncology (PYXS) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.243B 0.00
Akebia Therapeutics (AKBA) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.238B 0.00
Prelude Therapeutics (PRLD) United States $0.235B 0.00
Conduit Pharmaceuticals (CDT) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
CytoDyn (CYDY) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.148B 13.90
OptiNose (OPTN) United States $0.146B 0.00
Context Therapeutics (CNTX) United States $0.135B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
SCYNEXIS (SCYX) United States $0.091B 1.28
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.079B 0.00
Protara Therapeutics (TARA) United States $0.077B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.057B 0.00
Inotiv (NOTV) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Nutriband (NTRB) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
DURECT (DRRX) United States $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.96
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.44